Adam R. Schmitt, BA; Jerry D. Brewer, MD; Jeremy S. Bordeaux, MD, MPH; et al.
free access
JAMA Dermatol. 2014;150(1):19-24. doi:10.1001/jamadermatol.2013.6675
Schmitt et al analyze the stages in American Joint Committee on Cancer (AJCC) criteria and an alternative staging system most closely associated with positive sentinel lymph node biopsy findings in nonanogenital cutaneous squamous cell carcinoma (cSCC). See the editorial by Karia and Schmults.
Fanny Fichel, MD; Coralie Barbe, MD; Pascal Joly, MD, PhD; et al.
free access
JAMA Dermatol. 2014;150(1):25-33. doi:10.1001/jamadermatol.2013.5757
Fichel et al identify risk factors for disease relapse of bullous pemphigoid during the course of the first year of treatment from a large series of patients.
Astrid Vredenborg, MD; Stefan Böhringer, MD, PhD; Stephanie E. Boonk, MD; et al.
free access
JAMA Dermatol. 2014;150(1):35-40. doi:10.1001/jamadermatol.2013.5588
Vredenborg and coauthors examine whether acquired melanocytic nevi in childhood are an indicator of risk of melanoma in familial melanoma patients.
Faustine Ferrari, MD; Alice Masurel, MD; Laurence Olivier-Faivre, MD, PhD; et al.
free access
JAMA Dermatol. 2014;150(1):42-46. doi:10.1001/jamadermatol.2013.6434
Ferrari and coauthors evaluate the frequency, clinical characteristics, and diagnostic value of juvenile xanthogranuloma (JXG) and nevus anemicus (NA) in patients with neurofibromatosis type 1.
Patsy Lenane, MB, BCh, BAO, MRCPI; Colin Macarthur, MBChB, PhD; Patricia C. Parkin, MD, FRCPC; et al.
free access
JAMA Dermatol. 2014;150(1):47-50. doi:10.1001/jamadermatol.2013.5764
Lenane and coauthors compare the efficacy and safety of a high- vs low-potency topical corticosteroid in pediatric patients.
Kristie L. Akamine, MD; Cheryl J. Gustafson, MD; Scott A. Davis, MA; et al.
free access
JAMA Dermatol. 2014;150(1):51-55. doi:10.1001/jamadermatol.2013.4741
Akamine and coauthors used data from the National Ambulatory Medical Care Survey to determine whether physicians are following suggested patient-education guidelines regarding sun protection and to assess the association of those data with patient demographics, physician specialty, and physician diagnosis.
Mahsa Amir, MD; Blake P. Sampson, MD; Dawnielle Endly, DO; et al.
free access
JAMA Dermatol. 2014;150(1):56-60. doi:10.1001/jamadermatol.2013.6340
Amir et al evaluate and quantify the extent of involvement of dermatology journals, professional dermatology organizations, and dermatology-related patient advocate groups on social networking sites.